API Facilities

SHPL has got state of the art API facility. Our primary focus, based on extensive market research, is on manufacturing anti-diabetic medication. Estimated to be one of the fastest growing therapeutic segments, we at Sohan Healthcare currently manufacture Metformin Hydrochloride ( API) as a major API. Our dedicated team is currently working on lining up a battery of other medication that we will soon be able to manufacture


SHPL has got Pre-finish Formulation/ Directly compressible (DC / PFI) facility and shortly company is getting in to finish formulation. The facility is designed as per all word class standards to cater to all the global market. Shortly company is going for EU-GMP, CEP, US FDA, and rest all global approvals.

Formulation R & D - Company has in house state of the art formulation R & D Lab. Company can take up customer specific formulation development and give plant level trial. Even company can help client plant level production if needed. In short company can give complete solution right from product development to plant level regular production.

SHPL believes in complete integration right from API to formulation development to Pre finish manufacturing ( PFI/DC) and finally to finish formulation.

SHPL – A Complete integrated Company
Copyright © 2013 Sohan Healthcare All Rights Reserved. Disclaimer [Best viewed in IE7+, Firefox, Chrome , Safari, Opera.]